Skip to main content Skip to footer
HomeHome
 
  • Homepage
  • Searching for patents

    Patent knowledge

    Access our patent databases and search tools.

    Go to overview 

    • Overview
    • Technical information
      • Overview
      • Espacenet - patent search
      • European Publication Server
      • EP full-text search
    • Legal information
      • Overview
      • European Patent Register
      • European Patent Bulletin
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Overview
      • PATSTAT
      • IPscore
      • Technology insight reports
    • Data
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
      • Web services
      • Coverage, codes and statistics
    • Technology platforms
      • Overview
      • Plastics in transition
      • Water innovation
      • Space innovation
      • Technologies combatting cancer
      • Firefighting technologies
      • Clean energy technologies
      • Fighting coronavirus
    • Helpful resources
      • Overview
      • First time here?
      • Asian patent information
      • Patent information centres
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
    Image
    Plastics in Transition

    Technology insight report on plastic waste management

  • Applying for a patent

    Applying for a patent

    Practical information on filing and grant procedures.

    Go to overview 

    • Overview
    • European route
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
      • Appeals
      • Unitary Patent & Unified Patent Court
      • National validation
      • Request for extension/validation
    • International route (PCT)
      • Overview
      • Euro-PCT Guide – PCT procedure at the EPO
      • EPO decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
      • Training and events
    • National route
    • Find a professional representative
    • MyEPO services
      • Overview
      • Understand our services
      • Get access
      • File with us
      • Interact with us on your files
      • Online Filing & fee payment outages
    • Forms
      • Overview
      • Request for examination
    • Fees
      • Overview
      • European fees (EPC)
      • International fees (PCT)
      • Unitary Patent fees (UP)
      • Fee payment and refunds
      • Warning

    UP

    Find out how the Unitary Patent can enhance your IP strategy

  • Law & practice

    Law & practice

    European patent law, the Official Journal and other legal texts.

    Go to overview 

    • Overview
    • Legal texts
      • Overview
      • European Patent Convention
      • Official Journal
      • Guidelines
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
      • Unitary patent system
      • National measures relating to the Unitary Patent
    • Court practices
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
    Image
    Law and practice scales 720x237

    Keep up with key aspects of selected BoA decisions with our monthly "Abstracts of decisions”

  • News & events

    News & events

    Our latest news, podcasts and events, including the European Inventor Award.

    Go to overview 

     

    • Overview
    • News
    • Events
    • European Inventor Award
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • European Inventor Network
      • The 2024 event
    • Young Inventor Prize
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
    • Press centre
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • Innovation and patenting in focus
      • Overview
      • Water-related technologies
      • CodeFest
      • Green tech in focus
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
      • The future of medicine
      • Materials science
      • Mobile communications
      • Biotechnology
      • Patent classification
      • Digital technologies
      • The future of manufacturing
      • Books by EPO experts
    • "Talk innovation" podcast

    Podcast

    From ideas to inventions: tune into our podcast for the latest in tech and IP

  • Learning

    Learning

    The European Patent Academy – the point of access to your learning

    Go to overview 

    • Overview
    • Learning activities and paths
      • Overview
      • Learning activities
      • Learning paths
    • EQE and EPAC
      • Overview
      • EQE - European qualifying examination
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Overview
      • Business and IP managers
      • EQE and EPAC Candidates
      • Judges, lawyers and prosecutors
      • National offices and IP authorities
      • Patent attorneys and paralegals
      • Universities, research centres and technology transfer centres (TTOs)
    Image
    Patent Academy catalogue

    Have a look at the extensive range of learning opportunities in the European Patent Academy training catalogue

  • About us

    About us

    Find out more about our work, values, history and vision

    Go to overview 

    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Overview
      • Official celebrations
      • Member states’ video statements
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Overview
      • Legal foundations
      • Member states of the European Patent Organisation
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Overview
      • Communiqués
      • Calendar
      • Documents and publications
      • Administrative Council
    • Principles & strategy
      • Overview
      • Our mission, vision, values and corporate policy
      • Strategic Plan 2028
      • Towards a New Normal
    • Leadership & management
      • Overview
      • President António Campinos
      • Management Advisory Committee
    • Sustainability at the EPO
      • Overview
      • Environmental
      • Social
      • Governance and Financial sustainability
    • Services & activities
      • Overview
      • Our services & structure
      • Quality
      • Consulting our users
      • European and international co-operation
      • European Patent Academy
      • Chief Economist
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Overview
      • Innovation actors
      • Policy and funding
      • Tools
      • About the Observatory
    • Procurement
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Sustainable Procurement Policy
      • About eTendering and electronic signatures
      • Procurement portal
      • Invoicing
      • General conditions
      • Archived tenders
    • Transparency portal
      • Overview
      • General
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
      • "Long Night"
    Image
    Patent Index 2024 keyvisual showing brightly lit up data chip, tinted in purple, bright blue

    Track the latest tech trends with our Patent Index

 
Website
cancel
en de fr
  • Language selection
  • English
  • Deutsch
  • Français
Main navigation
  • Homepage
    • Go back
    • New to patents
  • New to patents
    • Go back
    • Your business and patents
    • Why do we have patents?
    • What's your big idea?
    • Are you ready?
    • What to expect
    • How to apply for a patent
    • Is it patentable?
    • Are you first?
    • Patent quiz
    • Unitary patent video
  • Searching for patents
    • Go back
    • Overview
    • Technical information
      • Go back
      • Overview
      • Espacenet - patent search
        • Go back
        • Overview
        • National patent office databases
        • Global Patent Index (GPI)
        • Release notes
      • European Publication Server
        • Go back
        • Overview
        • Release notes
        • Cross-reference index for Euro-PCT applications
        • EP authority file
        • Help
      • EP full-text search
    • Legal information
      • Go back
      • Overview
      • European Patent Register
        • Go back
        • Overview
        • Release notes archive
        • Register documentation
          • Go back
          • Overview
          • Deep link data coverage
          • Federated Register
          • Register events
      • European Patent Bulletin
        • Go back
        • Overview
        • Download Bulletin
        • EP Bulletin search
        • Help
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Go back
      • Overview
      • PATSTAT
      • IPscore
        • Go back
        • Release notes
      • Technology insight reports
    • Data
      • Go back
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
        • Go back
        • Overview
        • Manuals
        • Sequence listings
        • National full-text data
        • European Patent Register data
        • EPO worldwide bibliographic data (DOCDB)
        • EP full-text data
        • EPO worldwide legal event data (INPADOC)
        • EP bibliographic data (EBD)
        • Boards of Appeal decisions
      • Web services
        • Go back
        • Overview
        • Open Patent Services (OPS)
        • European Publication Server web service
      • Coverage, codes and statistics
        • Go back
        • Weekly updates
        • Updated regularly
    • Technology platforms
      • Go back
      • Overview
      • Plastics in transition
        • Go back
        • Overview
        • Plastics waste recovery
        • Plastics waste recycling
        • Alternative plastics
      • Innovation in water technologies
        • Go back
        • Overview
        • Clean water
        • Protection from water
      • Space innovation
        • Go back
        • Overview
        • Cosmonautics
        • Space observation
      • Technologies combatting cancer
        • Go back
        • Overview
        • Prevention and early detection
        • Diagnostics
        • Therapies
        • Wellbeing and aftercare
      • Firefighting technologies
        • Go back
        • Overview
        • Detection and prevention of fires
        • Fire extinguishing
        • Protective equipment
        • Post-fire restoration
      • Clean energy technologies
        • Go back
        • Overview
        • Renewable energy
        • Carbon-intensive industries
        • Energy storage and other enabling technologies
      • Fighting coronavirus
        • Go back
        • Overview
        • Vaccines and therapeutics
          • Go back
          • Overview
          • Vaccines
          • Overview of candidate therapies for COVID-19
          • Candidate antiviral and symptomatic therapeutics
          • Nucleic acids and antibodies to fight coronavirus
        • Diagnostics and analytics
          • Go back
          • Overview
          • Protein and nucleic acid assays
          • Analytical protocols
        • Informatics
          • Go back
          • Overview
          • Bioinformatics
          • Healthcare informatics
        • Technologies for the new normal
          • Go back
          • Overview
          • Devices, materials and equipment
          • Procedures, actions and activities
          • Digital technologies
        • Inventors against coronavirus
    • Helpful resources
      • Go back
      • Overview
      • First time here?
        • Go back
        • Overview
        • Basic definitions
        • Patent classification
          • Go back
          • Overview
          • Cooperative Patent Classification (CPC)
        • Patent families
          • Go back
          • Overview
          • DOCDB simple patent family
          • INPADOC extended patent family
        • Legal event data
          • Go back
          • Overview
          • INPADOC classification scheme
      • Asian patent information
        • Go back
        • Overview
        • China (CN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Chinese Taipei (TW)
          • Go back
          • Overview
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • India (IN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
        • Japan (JP)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Korea (KR)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Russian Federation (RU)
          • Go back
          • Overview
          • Facts and figures
          • Numbering system
          • Searching in databases
        • Useful links
      • Patent information centres (PATLIB)
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
  • Applying for a patent
    • Go back
    • Overview
    • European route
      • Go back
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
        • Go back
        • Oral proceedings calendar
          • Go back
          • Calendar
          • Public access to appeal proceedings
          • Public access to opposition proceedings
          • Technical guidelines
      • Appeals
      • Unitary Patent & Unified Patent Court
        • Go back
        • Overview
        • Unitary Patent
          • Go back
          • Overview
          • Legal framework
          • Main features
          • Applying for a Unitary Patent
          • Cost of a Unitary Patent
          • Translation and compensation
          • Start date
          • Introductory brochures
        • Unified Patent Court
      • National validation
      • Extension/validation request
    • International route
      • Go back
      • Overview
      • Euro-PCT Guide
      • Entry into the European phase
      • Decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
        • Go back
        • Patent Prosecution Highway (PPH) programme outline
      • Training and events
    • National route
    • MyEPO services
      • Go back
      • Overview
      • Understand our services
        • Go back
        • Overview
        • Exchange data with us using an API
          • Go back
          • Release notes
      • Get access
        • Go back
        • Overview
        • Release notes
      • File with us
        • Go back
        • Overview
        • What if our online filing services are down?
        • Release notes
      • Interact with us on your files
        • Go back
        • Release notes
      • Online Filing & fee payment outages
    • Fees
      • Go back
      • Overview
      • European fees (EPC)
        • Go back
        • Overview
        • Decisions and notices
      • International fees (PCT)
        • Go back
        • Reduction in fees
        • Fees for international applications
        • Decisions and notices
        • Overview
      • Unitary Patent fees (UP)
        • Go back
        • Overview
        • Decisions and notices
      • Fee payment and refunds
        • Go back
        • Overview
        • Payment methods
        • Getting started
        • FAQs and other documentation
        • Technical information for batch payments
        • Decisions and notices
        • Release notes
      • Warning
    • Forms
      • Go back
      • Overview
      • Request for examination
    • Find a professional representative
  • Law & practice
    • Go back
    • Overview
    • Legal texts
      • Go back
      • Overview
      • European Patent Convention
        • Go back
        • Overview
        • Archive
          • Go back
          • Overview
          • Documentation on the EPC revision 2000
            • Go back
            • Overview
            • Diplomatic Conference for the revision of the EPC
            • Travaux préparatoires
            • New text
            • Transitional provisions
            • Implementing regulations to the EPC 2000
            • Rules relating to Fees
            • Ratifications and accessions
          • Travaux Préparatoires EPC 1973
      • Official Journal
      • Guidelines
        • Go back
        • Overview
        • EPC Guidelines
        • PCT-EPO Guidelines
        • Unitary Patent Guidelines
        • Guidelines revision cycle
        • Consultation results
        • Summary of user responses
        • Archive
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
        • Go back
        • Overview
        • Archive
      • Unitary Patent system
        • Go back
        • Travaux préparatoires to UP and UPC
      • National measures relating to the Unitary Patent 
    • Court practices
      • Go back
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Go back
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Go back
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
  • News & events
    • Go back
    • Overview
    • News
    • Events
    • European Inventor Award
      • Go back
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the inventors
      • Nominations
      • European Inventor Network
        • Go back
        • 2024 activities
        • 2025 activities
        • Rules and criteria
        • FAQ
      • The 2024 event
    • Young Inventors Prize
      • Go back
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
      • The 2025 event
    • Press centre
      • Go back
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
        • Go back
        • Overview
        • European Patent Office
        • Q&A on patents related to coronavirus
        • Q&A on plant patents
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • In focus
      • Go back
      • Overview
      • Water-related technologies
      • CodeFest
        • Go back
        • CodeFest Spring 2025 on classifying patent data for sustainable development
        • Overview
        • CodeFest 2024 on generative AI
        • CodeFest 2023 on Green Plastics
      • Green tech in focus
        • Go back
        • Overview
        • About green tech
        • Renewable energies
        • Energy transition technologies
        • Building a greener future
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
        • Go back
        • Overview
        • Patents and space technologies
      • Healthcare
        • Go back
        • Overview
        • Medical technologies and cancer
        • Personalised medicine
      • Materials science
        • Go back
        • Overview
        • Nanotechnology
      • Mobile communications
      • Biotechnology
        • Go back
        • Overview
        • Red, white or green
        • The role of the EPO
        • What is patentable?
        • Biotech inventors
      • Classification
        • Go back
        • Overview
        • Nanotechnology
        • Climate change mitigation technologies
          • Go back
          • Overview
          • External partners
          • Updates on Y02 and Y04S
      • Digital technologies
        • Go back
        • Overview
        • About ICT
        • Hardware and software
        • Artificial intelligence
        • Fourth Industrial Revolution
      • Additive manufacturing
        • Go back
        • Overview
        • About AM
        • AM innovation
      • Books by EPO experts
    • Podcast
  • Learning
    • Go back
    • Overview
    • Learning activities and paths
      • Go back
      • Overview
      • Learning activities: types and formats
      • Learning paths
    • EQE and EPAC
      • Go back
      • Overview
      • EQE - European Qualifying Examination
        • Go back
        • Overview
        • Compendium
          • Go back
          • Overview
          • Paper F
          • Paper A
          • Paper B
          • Paper C
          • Paper D
          • Pre-examination
        • Candidates successful in the European qualifying examination
        • Archive
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Go back
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Go back
      • Overview
      • Business and IP managers
        • Go back
        • Overview
        • Innovation case studies
          • Go back
          • Overview
          • SME case studies
          • Technology transfer case studies
          • High-growth technology case studies
        • Inventor's handbook
          • Go back
          • Overview
          • Introduction
          • Disclosure and confidentiality
          • Novelty and prior art
          • Competition and market potential
          • Assessing the risk ahead
          • Proving the invention
          • Protecting your idea
          • Building a team and seeking funding
          • Business planning
          • Finding and approaching companies
          • Dealing with companies
        • Best of search matters
          • Go back
          • Overview
          • Tools and databases
          • EPO procedures and initiatives
          • Search strategies
          • Challenges and specific topics
        • Support for high-growth technology businesses
          • Go back
          • Overview
          • Business decision-makers
          • IP professionals
          • Stakeholders of the Innovation Ecosystem
      • EQE and EPAC Candidates
        • Go back
        • Overview
        • Paper F brain-teasers
        • Daily D questions
        • European qualifying examination - Guide for preparation
        • EPAC
      • Judges, lawyers and prosecutors
        • Go back
        • Overview
        • Compulsory licensing in Europe
        • The jurisdiction of European courts in patent disputes
      • National offices and IP authorities
        • Go back
        • Overview
        • Learning material for examiners of national officers
        • Learning material for formalities officers and paralegals
      • Patent attorneys and paralegals
      • Universities, research centres and TTOs
        • Go back
        • Overview
        • Modular IP Education Framework (MIPEF)
        • Pan-European Seal Young Professionals Programme
          • Go back
          • Overview
          • For students
          • For universities
            • Go back
            • Overview
            • IP education resources
            • University memberships
          • Our young professionals
          • Professional development plan
        • Academic Research Programme
          • Go back
          • Overview
          • Completed research projects
          • Current research projects
        • IP Teaching Kit
          • Go back
          • Overview
          • Download modules
        • Intellectual property course design manual
        • PATLIB Knowledge Transfer to Africa
          • Go back
          • The PATLIB Knowledge Transfer to Africa initiative (KT2A)
          • KT2A core activities
          • Success story: Malawi University of Science and Technology and PATLIB Birmingham
  • About us
    • Go back
    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Go back
      • Official celebrations
      • Overview
      • Member states’ video statements
        • Go back
        • Albania
        • Austria
        • Belgium
        • Bulgaria
        • Croatia
        • Cyprus
        • Czech Republic
        • Denmark
        • Estonia
        • Finland
        • France
        • Germany
        • Greece
        • Hungary
        • Iceland
        • Ireland
        • Italy
        • Latvia
        • Liechtenstein
        • Lithuania
        • Luxembourg
        • Malta
        • Monaco
        • Montenegro
        • Netherlands
        • North Macedonia
        • Norway
        • Poland
        • Portugal
        • Romania
        • San Marino
        • Serbia
        • Slovakia
        • Slovenia
        • Spain
        • Sweden
        • Switzerland
        • Türkiye
        • United Kingdom
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Go back
      • Overview
      • Legal foundations
      • Member states
        • Go back
        • Overview
        • Member states by date of accession
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Go back
      • Overview
      • Communiqués
        • Go back
        • 2024
        • Overview
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
        • 2013
      • Calendar
      • Documents and publications
        • Go back
        • Overview
        • Select Committee documents
      • Administrative Council
        • Go back
        • Overview
        • Composition
        • Representatives
        • Rules of Procedure
        • Board of Auditors
        • Secretariat
        • Council bodies
    • Principles & strategy
      • Go back
      • Overview
      • Mission, vision, values & corporate policy
      • Strategic Plan 2028
        • Go back
        • Driver 1: People
        • Driver 2: Technologies
        • Driver 3: High-quality, timely products and services
        • Driver 4: Partnerships
        • Driver 5: Financial sustainability
      • Towards a New Normal
      • Data protection & privacy notice
    • Leadership & management
      • Go back
      • Overview
      • About the President
      • Management Advisory Committee
    • Sustainability at the EPO
      • Go back
      • Overview
      • Environmental
        • Go back
        • Overview
        • Inspiring environmental inventions
      • Social
        • Go back
        • Overview
        • Inspiring social inventions
      • Governance and Financial sustainability
    • Procurement
      • Go back
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Dynamic Purchasing System (DPS) publications
      • Sustainable Procurement Policy
      • About eTendering
      • Invoicing
      • Procurement portal
        • Go back
        • Overview
        • e-Signing contracts
      • General conditions
      • Archived tenders
    • Services & activities
      • Go back
      • Overview
      • Our services & structure
      • Quality
        • Go back
        • Overview
        • Foundations
          • Go back
          • Overview
          • European Patent Convention
          • Guidelines for examination
          • Our staff
        • Enabling quality
          • Go back
          • Overview
          • Prior art
          • Classification
          • Tools
          • Processes
        • Products & services
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
          • Continuous improvement
        • Quality through networking
          • Go back
          • Overview
          • User engagement
          • Co-operation
          • User satisfaction survey
          • Stakeholder Quality Assurance Panels
        • Patent Quality Charter
        • Quality Action Plan
        • Quality dashboard
        • Statistics
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
        • Integrated management at the EPO
      • Consulting our users
        • Go back
        • Overview
        • Standing Advisory Committee before the EPO (SACEPO)
          • Go back
          • Overview
          • Objectives
          • SACEPO and its working parties
          • Meetings
          • Single Access Portal – SACEPO Area
        • Surveys
          • Go back
          • Overview
          • Detailed methodology
          • Search services
          • Examination services, final actions and publication
          • Opposition services
          • Formalities services
          • Customer services
          • Filing services
          • Key Account Management (KAM)
          • Website
          • Archive
      • Our user service charter
      • European and international co-operation
        • Go back
        • Overview
        • Co-operation with member states
          • Go back
          • Overview
        • Bilateral co-operation with non-member states
          • Go back
          • Overview
          • Validation system
          • Reinforced Partnership programme
        • Multilateral international co-operation with IP offices and organisations
        • Co-operation with international organisations outside the IP system
      • European Patent Academy
        • Go back
        • Overview
        • Partners
      • Chief Economist
        • Go back
        • Overview
        • Economic studies
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Go back
      • Overview
      • Innovation against cancer
      • Innovation actors
        • Go back
        • Overview
        • Startups and SMEs
      • Policy and funding
        • Go back
        • Overview
        • Financing innovation programme
          • Go back
          • Overview
          • Our studies on the financing of innovation
          • EPO initiatives for patent applicants
          • Financial support for innovators in Europe
        • Patents and standards
          • Go back
          • Overview
          • Publications
          • Patent standards explorer
      • Tools
        • Go back
        • Overview
        • Deep Tech Finder
      • About the Observatory
        • Go back
        • Overview
        • Work plan
    • Transparency portal
      • Go back
      • Overview
      • General
        • Go back
        • Overview
        • Annual Review 2023
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • 50 years of the EPC
          • Strategic key performance indicators
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
        • Annual Review 2022
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Go back
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
        • Go back
        • Insight into computer technology and AI
        • Insight into clean energy technologies
        • Statistics and indicators
          • Go back
          • European patent applications
            • Go back
            • Key trend
            • Origin
            • Top 10 technical fields
              • Go back
              • Computer technology
              • Electrical machinery, apparatus, energy
              • Digital communication
              • Medical technology
              • Transport
              • Measurement
              • Biotechnology
              • Pharmaceuticals
              • Other special machines
              • Organic fine chemistry
            • All technical fields
          • Applicants
            • Go back
            • Top 50
            • Categories
            • Women inventors
          • Granted patents
            • Go back
            • Key trend
            • Origin
            • Designations
      • Data to download
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Go back
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Go back
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
        • Go back
        • Catalyst lab & Deep vision
          • Go back
          • Irene Sauter (DE)
          • AVPD (DK)
          • Jan Robert Leegte (NL)
          • Jānis Dzirnieks (LV) #1
          • Jānis Dzirnieks (LV) #2
          • Péter Szalay (HU)
          • Thomas Feuerstein (AT)
          • Tom Burr (US)
          • Wolfgang Tillmans (DE)
          • TerraPort
          • Unfinished Sculpture - Captives #1
          • Deep vision – immersive exhibition
          • Previous exhibitions
        • The European Patent Journey
        • Sustaining life. Art in the climate emergency
        • Next generation statements
        • Open storage
        • Cosmic bar
      • "Long Night"
  • Boards of Appeal
    • Go back
    • Overview
    • Decisions of the Boards of Appeal
      • Go back
      • Overview
      • Recent decisions
      • Selected decisions
    • Information from the Boards of Appeal
    • Procedure
    • Oral proceedings
    • About the Boards of Appeal
      • Go back
      • Overview
      • President of the Boards of Appeal
      • Enlarged Board of Appeal
        • Go back
        • Overview
        • Pending referrals (Art. 112 EPC)
        • Decisions sorted by number (Art. 112 EPC)
        • Pending petitions for review (Art. 112a EPC)
        • Decisions on petitions for review (Art. 112a EPC)
      • Technical Boards of Appeal
      • Legal Board of Appeal
      • Disciplinary Board of Appeal
      • Presidium
        • Go back
        • Overview
    • Code of Conduct
    • Business distribution scheme
      • Go back
      • Overview
      • Technical boards of appeal by IPC in 2025
      • Archive
    • Annual list of cases
    • Communications
    • Annual reports
      • Go back
      • Overview
    • Publications
      • Go back
      • Abstracts of decisions
    • Case Law of the Boards of Appeal
      • Go back
      • Overview
      • Archive
  • Service & support
    • Go back
    • Overview
    • Website updates
    • Availability of online services
      • Go back
      • Overview
    • FAQ
      • Go back
      • Overview
    • Publications
    • Ordering
      • Go back
      • Overview
      • Patent Knowledge Products and Services
      • Terms and conditions
        • Go back
        • Overview
        • Patent information products
        • Bulk data sets
        • Open Patent Services (OPS)
        • Fair use charter
    • Procedural communications
    • Useful links
      • Go back
      • Overview
      • Patent offices of member states
      • Other patent offices
      • Directories of patent attorneys
      • Patent databases, registers and gazettes
      • Disclaimer
    • Contact us
      • Go back
      • Overview
      • Filing options
      • Locations
    • Subscription centre
      • Go back
      • Overview
      • Subscribe
      • Change preferences
      • Unsubscribe
    • Official holidays
    • Glossary
    • RSS feeds
Board of Appeals
Decisions

Recent decisions

Overview
  • 2025 decisions
  • 2024 decisions
  • 2023 decisions
  1. Home
  2. T 1853/13 30-09-2014
Facebook X Linkedin Email

T 1853/13 30-09-2014

European Case Law Identifier
ECLI:EP:BA:2014:T185313.20140930
Date of decision
30 September 2014
Case number
T 1853/13
Petition for review of
-
Application number
01926782.2
IPC class
A23L 1/30
A23G 1/00
A23G 3/00
A23L 1/305
C07D 311/62
A23L 1/308
A23L 2/52
A61K 36/00
A61K 31/35
Language of proceedings
EN
Distribution
NO DISTRIBUTION (D)

Download and more information:

Decision in EN 454.96 KB
Documentation of the appeal procedure can be found in the European Patent Register
Bibliographic information is available in:
EN
Versions
Unpublished
Application title

COMPOSITIONS AND METHODS FOR IMPROVING VASCULAR HEALTH

Applicant name
MARS, INCORPORATED
Opponent name
Raisio Nutrition Ltd.
Board
3.3.09
Headnote
-
Relevant legal provisions
European Patent Convention Art 123(2)
Keywords

Amendments - Added subject-matter (yes)

Amendments - all requests

Catchword
-
Cited decisions
T 0686/99
Citing decisions
T 1150/15
T 2514/16

I. Mention of the grant of European patent No. 1 274 319 in the name of Mars Incorporated was published on 12 August 2009 (Bulletin 2009/33). The patent was granted with 15 claims. Claims 1 and 8 read as follows:

"1. A non-chocolate food product comprising (i) cocoa procyanidins selected from cocoa procyanidin monomers and oligomers derived from said monomers, and (ii) a sterol and/or stanol based cholesterol lowering agent; wherein the cocoa procyanidin monomers have the formula:

FORMULA/TABLE/GRAPHIC

and the oligomers comprise from 2 to 18 monomeric units connected via interflavan linkages of (4->6) and/or (4->8); and wherein the food product comprises at least 10 mug/g of cocoa procyanidins."

"8. A cholesterol reducing chocolate comprising (i) cocoa procyanidins selected from cocoa procyanidin monomers and oligomers derived from said monomers, and (ii) a sterol and/or stanol based cholesterol lowering agent; wherein the cocoa procyanidin monomers have the formula:

FORMULA/TABLE/GRAPHIC

and the oligomers comprise from 2 to 18 monomeric units connected via interflavan linkages of (4->6) and/or (4->8); and wherein the chocolate is either a dark chocolate comprising at least 3,600 mug of cocoa procyanidins per gram of chocolate, or a milk chocolate comprising at least 1,000 mug of cocoa procyanidins per gram of chocolate, the amounts being based on the total amount of nonfat cocoa solids in the product."

II. A notice of opposition was filed on 12 May 2010 by Raisio Nutrition Ltd., requesting revocation of the patent in its entirety inter alia on the ground of Article 100(c) EPC.

III. By a decision announced orally on 5 June 2013 and issued in writing on 21 June 2013 the opposition division revoked the patent. It held that the main request filed during the oral proceedings was not admissible and that the subject-matter of all independent claims of each auxiliary request, namely auxiliary requests 1 to 6 filed on 3 June 2013, infringed Article 123(2) EPC.

For the purposes of the present decision only auxiliary requests 2, 5 and 6 are of relevance. These requests contained an independent claim relating to a non-chocolate food product (claim 1 of all these requests) as well as an independent claim relating to a cholesterol-reducing chocolate (claim 6 of auxiliary requests 2 and 5).

Auxiliary request 2

Independent claims 1 and 6 of auxiliary request 2 read as follows:

"1. A non-chocolate food product comprising (i) cocoa procyanidins selected from cocoa procyanidin monomers and oligomers derived from said monomers, and (ii) a sterol and/or stanol based cholesterol lowering agent; wherein the cocoa procyanidin monomers have the formula:

FORMULA/TABLE/GRAPHIC

and the oligomers comprise from 2 to 10 monomeric units connected via interflavan linkages of (4->6) and/or (4->8); wherein the food product comprises at least 100 mug/g of cocoa procyanidins and from 0.5 g - 10 g per 45 g serving size of sterols/stanols; and wherein the cocoa procyanidins are present in the form of (i) a procyanidin-containing cocoa extract, or (ii) a fraction of the cocoa extract containing at least one procyanidin monomer or oligomer."

"6. A cholesterol reducing chocolate comprising (i) cocoa procyanidins selected from cocoa procyanidin monomers and oligomers derived from said monomers, and (ii) a sterol and/or stanol based cholesterol lowering agent; wherein the cocoa procyanidin monomers have the formula:

FORMULA/TABLE/GRAPHIC

and the oligomers comprise from 2 to 10 monomeric units connected via interflavan linkages of (4->6) and/or (4->8); and wherein the chocolate is either a dark chocolate comprising at least 10,000 mug of cocoa procyanidins per gram of chocolate, or a milk chocolate comprising at least 5,000 mug of cocoa procyanidins per gram of chocolate, the amounts being based on the total amount of nonfat cocoa solids in the product."

Auxiliary request 5

Independent claim 1 of auxiliary request 5 reads as follows:

"1. A non-chocolate food product comprising (i) a cocoa extract containing cocoa procyanidins selected from cocoa procyanidin monomers and oligomers derived from said monomers, and (ii) a sterol and/or stanol based cholesterol lowering agent; wherein the cocoa procyanidin monomers have the formula:

FORMULA/TABLE/GRAPHIC

and the oligomers comprise from 2 to 10 monomeric units connected via interflavan linkages of (4->6) and/or (4->8); wherein the food product comprises at least 100 mug/g of cocoa procyanidins and from 0.5 g - 10 g per 45 g serving size of sterols/stanols."

Independent claim 6 of auxiliary request 5 is identical to independent claim 6 of auxiliary request 2.

Auxiliary request 6

The sole independent claim 1 of auxiliary request 6 is identical to independent claim 1 of auxiliary

request 5.

The opposition division accepted that basis for the preferred procyanidins to be selected from monomers or oligomers having 2 to 10 monomeric units was to be found on page 4 of the application as filed, and that the required levels for the procyanidins were disclosed on page 14 for the non-chocolate food products and on page 15 for the chocolate food products. However, these levels were provided for the total of cocoa procyanidins (reference was made to pages 14 and 15) or cocoa polyphenols (page 20), including oligomers with monomeric units higher than 10. Therefore the levels disclosed on pages 14 and 15 could not be attributed to the specific claimed monomers or oligomers with 10 or less monomeric units. In the same way, the amounts of sterols/stanols per 45 g serving size (reference was made to page 15, last paragraph) were disclosed in the context of the procyanidins in general and not of procyanidins oligomers comprising from 2 to 10 monomeric units.

IV. On 21 August 2013 the patent proprietor (in the following: the appellant) filed an appeal against the decision of the opposition division and on the same day paid the appeal fee. On 1 November 2013 the appellant filed a statement setting out the grounds of appeal together with a new main request and new auxiliary requests 1 to 6.

The new main request and new auxiliary request 1 are irrelevant for this decision since they were withdrawn at the beginning of the oral proceedings before the board.

The new auxiliary requests 2, 3 and 4 correspond to auxiliary requests 2, 5 and 6 of the appealed decision (cf. above point III).

The new auxiliary request 5 corresponds to auxiliary request 5 of the appealed decision in all but two aspects:

(i) the sterol/stanol concentration in claim 1 is limited to "2 g - 4.5 g per 45 g serving size" and

(ii) claim 10 (relating to a package for a food product as defined in the previous claims and a label and/or instructions) is cancelled.

The new auxiliary request 6 contains only claims relating to cholesterol-lowering chocolate, which correspond to claims 6 to 9 of auxiliary request 2 before the opposition division and which have been renumbered as claims 1 to 4.

The appellant requested that the decision of the opposition division be set aside and that if the claims of one of the main or auxiliary requests were found to meet the requirements of Article 123(2) EPC, the case be remitted to the opposition division for consideration of the other grounds of opposition raised in the opposition proceedings.

V. By letter of 17 March 2014 the opponent (in the following: the respondent) filed observations on the appeal.

VI. In a communication dated 21 May 2014 the board expressed its preliminary non-binding opinion.

VII. On 30 September 2014 oral proceedings were held before the board. At the beginning of the oral proceedings the appellant withdrew the new main request and the new auxiliary request 1.

VIII. The relevant arguments put forward by the appellant in its written submissions and during the oral proceedings may be summarised as follows:

Auxiliary request 2

- The subject-matter of claim 1 met the requirements of Article 123(2) EPC, since the skilled person would directly and unambiguously derive it from the application as filed. The skilled person would start from the preferred embodiment disclosed on the final paragraph of page 14 concerning a non-chocolate food product containing a cholesterol-lowering agent. According to this embodiment the most preferred amount of cocoa procyanidins (threshold value) is "at least 100 mug/g" which would be understood by the skilled person as not restricted by any specific upper limit. This upper limit would be determined by manufacturing considerations and taste limitations.

- The structural formula of the cocoa procyanidin monomers was disclosed on page 5, which also disclosed the most preferred number of monomeric units for the procyanidin oligomers, namely 2 to 10.

- On page 5, lines 8-11, it was disclosed that cocoa procyanidins could be added in the form of an extract or an extract fraction.

- The disclosure that sterols/stanols could be used as cholesterol-lowering agents was provided on page 14, first full paragraph. The amount of 0.5 g to 10 g per 45 g serving size was disclosed on page 15, lines 30-31.

- With regard to the selection of 2 to 10 monomeric units for the oligomers present in cocoa procyanidins, the range of 2 to 10 units was the most preferred degree of polymerisation, which would directly and unambiguously be selected by the skilled person according to established practice. This selection was also supported by the disclosure of example 3 (reference was made to page 24). In this example a procyanidin standard was used which contained dimers through decamers. This meant that the skilled person would find clear instructions in the application as filed to combine such oligomers with the most preferred amount of 100 mug of cocoa procyanidins per g of non-chocolate food product as disclosed on page 14.

- Regarding the amount of sterols/stanols per 45 g service size disclosed on page 15, lines 30-31, the skilled person would legitimately consider the combination with the most preferred amount of 100 mug of cocoa procyanidin per gram of non-chocolate food product.

- With regard to the presence of the cocoa procyanidins in the form of an extract, this was disclosed in claim 8 as filed. Anyway, the skilled person would consider the cocoa extract as the most usual form in which the cocoa procyanidin could be used for the manufacture of such products.

Auxiliary request 3-5

- The arguments put forward for auxiliary request 2 likewise applied to auxiliary requests 3-5, which therefore met the requirements of Article 123(2) EPC.

Auxiliary request 6

- The subject-matter of claim 1 of auxiliary request 6 met the requirements of Article 123(2) EPC, as the skilled person would directly and unambiguously derive it from the application as filed. The claimed cholesterol-reducing chocolate, which combined cocoa procyanidins and a sterol/stanol cholesterol-lowering agent, was disclosed in claim 17 as filed. The feature relating to dark chocolate with 10,000 mug of cocoa procyanidins per gram of chocolate was disclosed on page 15, first paragraph. The feature relating to milk chocolate with at least 5,000 mug of cocoa procyanidins per gram of chocolate was disclosed on page 15, second paragraph.

- Regarding the term "at least" in the expression "at least 10,000 mug" of claim 1, which was not disclosed in the corresponding passage of the application as filed, the appellant requested to have it deleted if this was considered by the board as the only deficiency under Article 123(2) EPC.

- The combination of the nature of cocoa procyanidins, namely oligomers comprising from 2 to 10 monomeric units, with the amount of the cocoa procyanidins, namely 10,000 mug of cocoa procyanidins per gram of dark chocolate or with at least 5,000 mug per gram of milk chocolate, derived from the application as filed since the selected monomeric units and the selected amounts of cocoa procyanidins were of the same hierarchical level, namely the most preferred embodiment.

IX. The relevant arguments put forward by the respondent in its written submissions and during the oral proceedings may be summarised as follows:

Auxiliary request 2

- The subject-matter of claim 1 did not meet the requirements of Article 123(2) EPC. There was no direct and unambiguous disclosure in the application as filed of a non-chocolate food product combining the claimed specific cocoa procyanidins with the specific cholesterol lowering agents. This concerned in particular the specific formula of cocoa procyanidin, the specific number of monomeric units comprised in the oligomer, the specific amount of cocoa procyanidins in the food product including the absence of an upper limit for this amount, the specific amount of sterols/stanols per 45 g serving size and the specific form of the cocoa procyanidins.

- The level of preference, namely "most preferred" as argued by the appellant, for the combination of the number of monomeric units in the cocoa procyanidin oligomer (page 5, penultimate paragraph) and for the amount of cocoa procyanidins (page 14, last paragraph) could not be considered as a valid criterion for the combination of the corresponding features.

- The application as filed concerned procyanidin monomer and oligomers with up to 18 monomeric units, the amount of which in the non-chocolate food product was most preferably at least 100 mug. There was, however, no disclosure of the proportion of the cocoa procyanidin oligomers with up to 10 monomeric units within the total amount of procyanidins in the non-chocolate food product. Thus, the combination of the range of monomeric units 2-10 with the total amount of cocoa procyanidins did not meet the requirements of Article 123(2) EPC.

- Additionally, the application as filed (page 14, last paragraph) disclosed an upper limit of 10mg/g for the amount of cocoa procyanidins which was absent from claim 1. This was another reason why claim 1 did not meet the requirements of Article 123(2) EPC.

- The presence of the cocoa procyanidins in the form of an extract did not derive from page 5, lines 6-12. This passage concerned cocoa polyphenols in general and clearly indicated that the cocoa polyphenols might be added "independently of cocoa ingredients", i.e. not necessarily as a chocolate liquor in chocolate, the latter being absent from the claimed subject-matter.

- The claimed form of cocoa procyanidins was not disclosed in claim 8 as filed, which depended on claim 5, the latter relating to "a food other than a confectionery" and not to the claimed "non-chocolate food product". Thus, this disclosure could not be used as base for this feature.

- Regarding the claimed sterols/stanols, they were simply examples of cholesterol lowering agents (bridging paragraph of pages 8 and 9; page 14, lines 7-8) and the skilled person would not necessarily combine them with the other features of the claim.

Auxiliary requests 3-5

- The subject-matter of claim 1 of these auxiliary requests suffered from the same defects as that of claim 1 of auxiliary request 2. These requests likewise did not meet the requirements of Article 123(2) EPC.

Auxiliary request 6

- The subject-matter of claim 1 did not meet the requirements of Article 123(2) EPC since it was not directly and unambiguously disclosed in the application as filed. This concerned the combination of a cholesterol-reducing chocolate combining the specific cholesterol-lowering agents sterols/stanols with the specific cocoa procyanidins in amounts of at least 10,000 mug per gram of dark chocolate or of at least 5,000 mug per gram of milk chocolate. The disclosed amounts of cocoa procyanidins in chocolate, be it dark or milk (page 15, lines 1-17), corresponded to the total amount of procyanidins and not to the specific oligomers with 2-10 monomeric units. Furthermore, these amounts related to chocolate confectionery in general and not only to dark or milk chocolate. There was, therefore, no direct and unambiguous link in the application as filed between the dark or milk chocolate and the amounts of at least 10,000 mug or 5,000 mug cocoa procyanidins per gram of chocolate.

X. The appellant requested that the decision under appeal be set aside and that, if one of the second to sixth auxiliary requests filed with the grounds of appeal were found to meet the requirements of Article 123(2) EPC, the case be remitted to the opposition division for consideration of the other grounds of opposition raised by the respondent.

XI. The respondent requested that the appeal be dismissed.

1. The appeal is admissible.

2. The requests

Since the appellant withdrew the main request and auxiliary request 1 during the oral proceedings before the board, this decision deals with the remaining auxiliary requests 2 to 6.

3. Auxiliary request 2

The respondent considered that the subject-matter of claim 1 of auxiliary request 2 was not directly and unambiguously disclosed in the application as filed and concluded that this claim did not meet the requirements of Article 123(2) EPC.

3.1 Claim 1 relates in general terms to a non-chocolate food product which comprises two components, namely

(i) cocoa procyanidins and

(ii) a cholesterol-lowering agent.

The only disclosure in the application as filed which comes close to such an embodiment is to be found on page 14, lines 28-31, which recites:

"In preferred embodiments, the non-chocolate food products containing a cholesterol lowering agent contains from about at least 5 mug/g to about 10 mg/g, and, for example, at least 5 mug/g food product, preferably at least 10 mug, more preferably at least 100 mug/g of cocoa procyanidins".

3.2 However, compared with this disclosure, claim 1 contains further features which define constituents (i) and (ii) more precisely. In the analysis which follows features (a) to (e) concern the cocoa procyanidins, and (f) and (g) the cholesterol-lowering agent:

(a) the cocoa procyanidins are selected from cocoa procyanidin monomers and oligomers derived from said monomers;

(b) the cocoa procyanidin monomers have the formula:

FORMULA/TABLE/GRAPHIC

(c) the oligomers comprise from 2 to 10 monomeric units connected via interflavan linkages of (4->6) and/or (4->8);

(d) the food product comprises at least 100 mug/g of cocoa procyanidins;

(e) the cocoa procyanidins are present in the form of (i) procyanidin-containing cocoa extract, or (ii) a fraction of the cocoa extract containing at least one procyanidin monomer or oligomer;

(f) the food product comprises a sterol and/or stanol based cholesterol lowering agent; and

(g) The food product comprises from 0.5 g - 10 g per 45 g serving size of sterols/stanols.

3.3 It is not disputed that each and every feature is disclosed in the application as filed.

Features (a) and (b) are disclosed on page 5, starting from line 12:

"The cocoa polyphenols include cocoa procyanidins, which may be monomers and/or oligomers of epicatechin and catechin. Procyanidin monomers include (+)-catechin, (-)epicatechin and their respective epimers (e.g. (-)-catechin and (+)-epicatechin) and have the structure

FORMULA/TABLE/GRAPHIC",

Feature (c) is disclosed on page 5, second full paragraph:

"The procyanidin oligomer may have from 2 to about 18, preferably from 2 to about 12, and most preferably from 2 to about 10 monomeric units ... In the oligomer, monomers are connected via interflavan linkages of (4->6) and/or (4->8)".

Feature (d) is disclosed on page 14, lines 28-31:

"In preferred embodiments, the non-chocolate food products containing a cholesterol lowering agent contains from about at least 5 mug/g to about 10mg/g and, for example, at least 5 mug/g food product, preferably at 10 mug, more preferably at least 100 mug/g of cocoa procyanidins".

Feature (e) is disclosed on page 5, starting from line 8:

"Cocoa polyphenols [i.e. cocoa procyanidins, in view of page 4, fourth paragraph, third sentence] may be included in the composition as ... an extract, extract fraction ...".

Feature (f) is disclosed in the bridging paragraph of pages 8/9 and to page 14, lines 7-8:

"The composition further comprises a cholesterol lowering agent ... Examples of suitable agents are phytosterols, phytostanols ..."

"The foods comprising cocoa polyphenols and at least one cholesterol lowering agent (e.g. a sterol and/or stanol based cholesterol lowering agent)..."

Feature (g) is disclosed on page 15, last paragraph:

"A food composition, for example, may contain from about 0.5 to about 10 g per 45 g serving size, preferably about 1.5 to about 5 g per 45 g serving size, most preferably about 2 to about 4.5 g per 45 g serving size of sterols stanols".

3.4 What is disputed is the disclosure of the combination of these features. In the following it is shown that the application as filed discloses an upper limit for the amount of cocoa procyanidins which is not part of feature (d) of claim 1, that the application as filed does not directly and unambiguously disclose the combination of features (c) and (d), and that it does not directly and unambiguously disclose the combination of the specific cholesterol-lowering agents in specific amounts with the specific cocoa procyanidin monomers in specific amounts, i.e. combination of features (a)-(e) with features (f) and (g).

3.4.1 Regarding the absence of an upper limit for the amount of the cocoa procyanidins, i.e. feature (d), the appellant referred to page 14, lines 28-31 (see point 3.1), and argued that in this passage the disclosure of "more preferably at least 100 mug/g of cocoa procyanidins" was to be interpreted so that the value of 100 mug/g concerned only the lower limit (threshold) of the amount of cocoa procyanidins, the upper limit depending on taste requirements (the cocoa procyanidins are relatively bitter) and on the manufacturing constraints.

However, the board does not agree with the appellant's assertion because this specific passage discloses the broadest definition of the amount of cocoa procyanidins, which is given in the form of a range, namely "from about at least 5 mug/g to about 10 mg/g". This clearly and unambiguously means that also the preferred and the more preferred amounts, namely

"at least 5 mug/g food product, preferably at least 10 mug, more preferably at least 100 mug/g of cocoa procyanidins",

are disclosed in the context of the broadest range and must necessarily have an upper limit at the value of 10 mg/g. Thus, feature (d), by not containing this upper limit, infringes the requirements of Article 123(2) EPC.

3.4.2 Regarding the combination of feature (c) with feature (d), it is remarked that nowhere in the application as filed can there be found a direct and unambiguous disclosure of the most preferred definition of the cocoa procyanidin oligomers, feature (c), with the most preferred amount of cocoa procyanidins, feature (d). The appellant argued that the combination of embodiments of the same level of preference, "the most preferred", is common practice. The board cannot accept this argument. The person skilled in the art would take from the relevant passage on page 14 of the application as filed that the levels of "cocoa procyanidins" refers to all cocoa procyanidins present in the food product and does not relate specifically to the content of the now claimed oligomers having 2 to 10 monomeric units. In the absence of a specific disclosure in the application as filed, the amounts referred to in the passage on page 14 cannot be attributed to the particular oligomers of feature (c).

The appellant also argued that this combination was supported by example 3 of the application as filed. The board disagrees with the appellant because example 3 merely discloses an attempt to quantify the totality of cocoa procyanidins in a beverage. It does not provide any information to the monomeric structure of the cocoa procyanidin oligomers involved and does not hint at any specific relation between the quantity measured and an oligomer comprising from 2 to 10 monomeric units. The reference in example 3 to a mixture of dimers through decamers of cocoa procyanidins concerns a commercial standard used for the quantification of the cocoa procyanidins in the beverage and has nothing to do with structure of the cocoa procyanidins in this beverage. The board concurs with the respondent that example 3 describes nothing else than an attempt to quantify the total cocoa procyanidins. There is no statement in this example that only a specific fraction of the cocoa procyanidins was measured.

3.4.3 Regarding the selection of the sterol and/or stanol cholesterol lowering agents, i.e. feature (f), it is noted that the relevant passage on page 14 is far more general and does not mention any specific cholesterol lowering agents. Sterols and/or stanols are disclosed on top of page 9 as examples of cholesterol lowering agents among other candidate products. The passage on page 14 does also not disclose any amount for the cholesterol lowering agents, i.e. feature (g). Thus, there is no direct and unambiguous disclosure in the application as filed for the combination of features (f) and (g), let alone in combination with the specific cocoa procyanidins in the specified amount now claimed, i.e. features (c) and (d).

3.5 In view of the above considerations, the board comes to the conclusion that the appellant has used the content of the original application as a reservoir from which features pertaining to separate embodiments were arbitrarily combined in order to artificially create a particular claim construction. Since there is no pointer to that particular combination, this combined selection of features does not, for the skilled person, emerge clearly and unambiguously from the content of the application as filed (in this context see T 686/99, point 4.3.3 of the reasons). Therefore, claim 1 of auxiliary request 2 contains subject-matter extending beyond the content of the original application, contrary to the requirements of Article 123(2) EPC.

4. Auxiliary requests 3 to 5

4.1 Claim 1 of auxiliary request 3 differs from claim 1 of auxiliary request 2 only in a slightly amended definition of the cocoa extract, i.e. feature (e) (for the exact wording see the identical claim 1 of auxiliary request 5 before the opposition division, point III above). However, in the same way as claim 1 of auxiliary request 2 the claim still provides no upper limit for the amount of the cocoa procyanidins, and combines specific cocoa procyanidins with specific sterol and/or stanol cholesterol-lowering agents. Thus, for the reasons given for claim 1 of auxiliary request 2 the combination of features in claim 1 of auxiliary request 3 is not considered to be directly and unambiguously disclosed in the application as filed with the consequence that this request infringes the requirements of Article 123(2) EPC.

4.2 Claim 1 of auxiliary request 4 is identical to claim 1 of auxiliary request 3 and likewise does not meet the requirements of Article 123(2) EPC.

4.3 Claim 1 of auxiliary request 5 differs from claim 1 of auxiliary 3 only in that a different amount of sterol and/or stanol cholesterol-lowering agent is used, namely 2 g to 4.5 g per 45 g serving size instead of 0.5 g to 10g. However this amendment does not overcome the objections with regard to Article 123(2) EPC. Thus, for the reason given for claim 1 of auxiliary request 2 the combination of features in claim 1 of auxiliary request 5 is not considered to be directly and unambiguously disclosed in the application as filed with the consequence that also this request infringes the requirements of Article 123(2) EPC.

5. Auxiliary request 6

The respondent considered that the subject-matter of claim 1 of auxiliary request 6 was not directly and unambiguously disclosed in the application as filed and concluded that this claim did not meet the requirements of Article 123(2) EPC.

5.1 Claim 1 is based on claim 17 as filed which discloses a cholesterol-reducing chocolate which comprises two essential components:

(i) cocoa procyanidins selected from cocoa procyanidin monomers and/or oligomers and

(ii) a sterol and/or stanol based cholesterol-lowering agent.

5.2 Compared with claim 17 as filed, claim 1 of auxiliary request 6 further specifies that:

- the oligomers of the cocoa procyanidins comprise from 2 to 10 monomeric units connected via interflavan linkages of (4->6) and/or (4->8) (feature (c), as defined in above point 3.2)

- the chocolate is a dark chocolate comprising at least 10,000 mug of cocoa procyanidins per gram of chocolate, the amounts being based on the total amount of nonfat cocoa solids in the product (feature (h)); or

- the chocolate is a milk chocolate comprising at least 5,000 mug of cocoa procyanidins per gram of chocolate, the amounts being based on the total amount of nonfat cocoa solids in the product (feature (j)).

5.3 Also in this case, the board does not dispute the fact that the added features (c), (h) and (j) are disclosed as such in the application as filed.

(It should be mentioned at this point that there is a discrepancy between claim 1 and the original description, since the claim requires that the amount is of at least 10,000 mug whereas the original description discloses that this amount is of 10,000 mug. However, during the oral proceedings the appellant requested amendment of claim 1 so that this discrepancy be removed if the board considered this discrepancy to be the only defect of claim 1 under Article 123(2) EPC).

5.4 However, the board considers that Article 123(2) EPC is infringed by the absence in the application as filed of a direct and unambiguous disclosure relating to the combination of all features, in particular the combination of the specific oligomers of the cocoa procyanidins with the specific amount of cocoa procyanidins. As already explained for the previous requests the level of cocoa procyanidins given in the application as filed refers to all cocoa procyanidins present and cannot be attributed to the particular oligomers of feature (c).

Hence, claim 1 of auxiliary request 6 contains subject-matter extending beyond the content of the application as filed, contrary to the requirements of Article 123(2) EPC.

6. In view of the above considerations none of the requests of the appellant meets the requirements of Article 123(2) EPC and the appeal has to be dismissed.

Order

For these reasons it is decided that:

The appeal is dismissed.

Footer - Service & support
  • Service & support
    • Website updates
    • Availability of online services
    • FAQ
    • Publications
    • Procedural communications
    • Contact us
    • Subscription centre
    • Official holidays
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
Facebook
European Patent Office
EPO Jobs
Instagram
EuropeanPatentOffice
Linkedin
European Patent Office
EPO Jobs
EPO Procurement
X (formerly Twitter)
EPOorg
EPOjobs
Youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility